SBRA — Sabra Health Care REIT Cashflow Statement
0.000.00%
Last trade - 00:00- $3.23bn
- $5.60bn
- $647.51m
- 73
- 60
- 45
- 61
Annual cashflow statement for Sabra Health Care REIT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 69 | 138 | -113 | -77.6 | 13.8 |
| Depreciation | |||||
| Non-Cash Items | 145 | 42.4 | 268 | 225 | 106 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -23.5 | -2.74 | 22.7 | -19.7 | -2.73 |
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | 372 | 355 | 356 | 316 | 301 |
| Capital Expenditures | -51.1 | -92.9 | -99.4 | -92.2 | -78.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 314 | -43.5 | -237 | -124 | 182 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 263 | -136 | -336 | -216 | 103 |
| Financing Cash Flow Items | -26.4 | -0.83 | -39.5 | -0.02 | -18.1 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -646 | -202 | 30.1 | -162 | -410 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -10.5 | 16.4 | 50.4 | -62 | -7.21 |